The Technology

Ozempic Is Not Just a Weight-Loss Story Anymore

via Vox·Aug 15

GLP-1 drugs are showing effects far beyond the scale, from addiction and inflammation to heart and kidney outcomes. Researchers are still working out how one class of drug touches so many systems at once.

Read Full Story at Vox
Health

Related Stories

Heat and Drought Take a Toll on Herders in Kenya and the United States

Phys.org·9h ago

Google’s Anti-Nausea Motion Assist Dots Roll Out on Android

Ars Technica·10h ago

A Woman Blind for Years Sees Again After the First Central Retina Transplant

Good News Network·10h ago

The Lindsay Clancy Murder Trial Nears Its End in Massachusetts

Reuters·11h ago
DiscussSoon
← Front Page